Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
67 hedge funds and large institutions have $280M invested in Syneron Medical Ltd in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 8 closing their positions.
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
30% more capital invested
Capital invested by funds: $215M → $280M (+$64.7M)
16% more funds holding
Funds holding: 58 → 67 (+9)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
22% less call options, than puts
Call options by funds: $18K | Put options by funds: $23K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$4.15M |
| 2 |
BC
Broadfin Capital
New York
|
+$2.08M |
| 3 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$2.08M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.01M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$724K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$25.8M |
| 2 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$2.33M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$1.59M |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$1.56M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$1.16M |
ELOS Hedge Fund Activity: Q4 2013 in Review
67 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2013, worth a combined $280M — up 30% from $215M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ELOS positions and 8 closed out — a net gain of 9 holders — while 14 added to existing stakes and 16 trimmed.
The largest buyer was Brandes Investment Partners, adding an estimated $4.15M. The largest seller was Senvest Management, exiting entirely with an estimated $25.8M sold.
- 67 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2013, up from 58 in Q3 2013.
- Funds reported $280M of Syneron Medical Ltd stock for Q4 2013, up 30% quarter-over-quarter.
- 17 funds opened new Syneron Medical Ltd positions in Q4 2013 and 8 closed out, a net change of +9 holders.
- The largest Syneron Medical Ltd buyer in Q4 2013 was Brandes Investment Partners, an estimated $4.15M added.
- The largest Syneron Medical Ltd seller in Q4 2013 was Senvest Management, an estimated $25.8M sold.
Based on aggregated 13F filings for Q4 2013.